LITHIUM AND ALZHEIMER’S DISEASE: POTENTIAL NEUROPROTECTIVE EFFECTS AND THERAPEUTIC PERSPECTIVES
Lithium is an established mood stabilizer whose possible use in Alzheimer’s disease (AD) has emerged from convergent molecular, animal, observational, and early clinical evidence. The principal rationale is that lithium may act on several processes implicated in AD rather than on a single lesion: glycogen synthase kina...